The Pharma Family Tree
View the corporate lineages of pharma's top companies.
With so many mergers and acquisitions lately, many of life pharmaceutical companies you grew up with many have disappeared, absorbed into other companies or spun out to make their way on their own. Here, the editors of Pharmaceutical technology trace the corporate lineages for the past 30 or so years for pharma's top 15 companies.
View the Pfizer/Wyeth family tree.
View the Abbott family tree.
View the Amgen family tree.
View the AstraZeneca family tree.
View the Bayer family tree.
View the Bristol-Myers Squibb family tree.
View the Glaxo SmithKline family tree.
View the Johnson " Johnson family tree.
View the Novartis family tree.
View the Eli Lilly family tree.
View the Roche family tree.
View the Sanofi-Aventis family tree.
View the Schering-Plough/Merck family tree.
Sources: www.abbott.com; www.amgen.com; www.astrazeneca.com; www.bayer.com; www.Bloomberg.com; www.bms.com; www.casebauer.net; www.fundinguniverse.com; www.gsk.com; www.jnj.com; www.merck.de; http://www.msd.com.hk/about_us/e_history_of_merck.html; www.Novartis.com; www.Pfizer.com; www.rocheusa.com; www.sanofi-aventis.co.uk; www.schering-plough.com; www.wyeth.com.
Read about the top 50 pharma companies in "Big Pharma Tightens Its Belt in Global Manufacturing."
Michelle Hoffman is editor-in-chief of Pharmaceutical Technology.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
